Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
出版年份 2020 全文链接
标题
Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 22, Pages 8627
出版商
MDPI AG
发表日期
2020-11-17
DOI
10.3390/ijms21228627
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combination therapy with oncolytic viruses and immune checkpoint inhibitors
- (2020) Matthew Chiu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Repurposing infectious disease vaccines for intratumoral immunotherapy
- (2020) Ignacio Melero et al. Journal for ImmunoTherapy of Cancer
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- Oncolytic viruses for cancer immunotherapy
- (2020) Otto Hemminki et al. Journal of Hematology & Oncology
- Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
- (2020) Luana Guerra et al. Cell Reports
- Genomic correlates of response to immune checkpoint blockade
- (2019) Tanya E. Keenan et al. NATURE MEDICINE
- Immunological impact of canerpaturev (C-REV, formerly HF10), an oncolytic viral immunotherapy, with or without ipilimumab (Ipi) for advanced solid tumor patients (pts).
- (2019) Takayuki Nakayama et al. JOURNAL OF CLINICAL ONCOLOGY
- Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
- (2019) Lukasz Kuryk et al. JOURNAL OF MEDICAL VIROLOGY
- Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells
- (2019) Biswajit Das et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
- (2019) Venkatesh Sivanandam et al. Molecular Therapy-Oncolytics
- Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma
- (2019) Robert H. I. Andtbacka et al. Journal for ImmunoTherapy of Cancer
- Immuno-oncology drug development goes global
- (2019) Jia Xin Yu et al. NATURE REVIEWS DRUG DISCOVERY
- Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
- (2019) Devalingam Mahalingam et al. CLINICAL CANCER RESEARCH
- Toxicities associated with checkpoint inhibitors—an overview
- (2019) Laura Spiers et al. RHEUMATOLOGY
- Recombinant Poliovirus for Cancer Immunotherapy
- (2018) Matthias Gromeier et al. Annual Review of Medicine
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
- (2018) Roberta Zappasodi et al. CANCER CELL
- The Development of Oncoltyic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer
- (2018) Mizuho Sato-Dahlman et al. CURRENT CANCER DRUG TARGETS
- Emergence of Ad-Mediated Combination Therapy Against Cancer: What to Expect?
- (2018) JinWoo Hong et al. CURRENT CANCER DRUG TARGETS
- Oncorine, the World First Oncolytic Virus Medicine and its Update in China
- (2018) Min Liang CURRENT CANCER DRUG TARGETS
- Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients
- (2018) Yasuhiro Fujisawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
- (2018) Nikolas Tim Martin et al. MOLECULAR THERAPY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
- (2018) Marie-Claude Bourgeois-Daigneault et al. Science Translational Medicine
- Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
- (2018) Adel Samson et al. Science Translational Medicine
- Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer
- (2018) Matthew J. Atherton et al. VACCINE
- Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
- (2018) Giulia Marelli et al. Frontiers in Immunology
- The advent of oncolytic virotherapy in oncology: The Rigvir® story
- (2018) Pēteris Alberts et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Single intravenous preoperative administration of the oncolytic virus Pexa-Vec to prime anti-tumor immunity.
- (2018) Alan Anthoney et al. JOURNAL OF CLINICAL ONCOLOGY
- Recombinant oncolytic poliovirus combined with checkpoint blockade for breast cancer therapy.
- (2018) Jeremy Force et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
- (2018) Jonathan G. Pol et al. OncoImmunology
- Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors
- (2018) Jonathan G. Pol et al. OncoImmunology
- Tumor microenvironment remodeling by intratumoral oncolytic vaccinia virus enhances the efficacy of immune checkpoint blockade
- (2018) Hong Jae Chon et al. CLINICAL CANCER RESEARCH
- Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
- (2018) Frank Stephen Hodi et al. LANCET ONCOLOGY
- ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)
- (2018) Gelareh Zadeh et al. NEURO-ONCOLOGY
- Second- and third-generation drugs for immuno-oncology treatment—The more the better?
- (2017) Wolfram C.M. Dempke et al. EUROPEAN JOURNAL OF CANCER
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
- (2017) Dmitriy Zamarin et al. Nature Communications
- Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
- (2017) Zuqiang Liu et al. Nature Communications
- TILT Biotherapeutics
- (2017) Akseli Hemminki Human Vaccines & Immunotherapeutics
- Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV
- (2017) Lauro Velazquez-Salinas et al. Human Gene Therapy Clinical Development
- Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
- (2017) Sam Illingworth et al. Molecular Therapy-Oncolytics
- Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
- (2017) Rocio Garcia-Carbonero et al. Journal for ImmunoTherapy of Cancer
- Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials
- (2017) Ibrahim Ragab Eissa et al. Frontiers in Oncology
- Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery
- (2017) Dana Haddad Frontiers in Oncology
- Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes
- (2017) Nalini Marino et al. PLoS One
- The MITCI (phase 1b) study: a novel immunotherapy combination of coxsackievirus A21 and ipilimumab in patients with advanced melanoma
- (2016) B. Curti et al. ANNALS OF ONCOLOGY
- Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer
- (2016) Adel Samson et al. GUT
- Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
- (2016) Igor Puzanov et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Johan F Vansteenkiste et al. LANCET ONCOLOGY
- Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
- (2016) Karishma Rajani et al. MOLECULAR THERAPY
- Erratum: Oncolytic viruses: a new class of immunotherapy drugs
- (2016) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Tremelimumab: research and clinical development
- (2016) Francisco Javier Ibarrondo et al. OncoTargets and Therapy
- Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model
- (2016) Eonju Oh et al. Oncotarget
- Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer
- (2016) Gulidanna Shayan et al. OncoImmunology
- Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
- (2016) Tuuli Ranki et al. Journal for ImmunoTherapy of Cancer
- Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
- (2016) Hasan Rehman et al. Journal for ImmunoTherapy of Cancer
- Oncolytic Viruses: Therapeutics With an Identity Crisis
- (2016) Caroline J. Breitbach et al. EBioMedicine
- Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus
- (2015) Chang Yoon Moon et al. BIOMATERIALS
- Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
- (2015) W. Shen et al. BLOOD
- Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
- (2015) F. J. Kohlhapp et al. CLINICAL CANCER RESEARCH
- Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance
- (2015) Volker Schirrmacher EXPERT OPINION ON BIOLOGICAL THERAPY
- Vaccinia virus, a promising new therapeutic agent for pancreatic cancer
- (2015) Chadwan Al Yaghchi et al. Immunotherapy
- The oncolytic virus, pelareorep, as a novel anticancer agent: a review
- (2015) Romit Chakrabarty et al. INVESTIGATIONAL NEW DRUGS
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic
- (2015) Caroline J Breitbach et al. Current Opinion in Virology
- Oncolytic viruses: From bench to bedside with a focus on safety
- (2015) Pascal RA Buijs et al. Human Vaccines & Immunotherapeutics
- Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer
- (2015) L Vassilev et al. OncoImmunology
- Abstract 2939: CAVATAK-mediated oncolytic immunotherapy in advanced melanoma patients
- (2015) Robert H. Andtbacka et al. CANCER RESEARCH
- Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers
- (2014) T Du et al. CANCER GENE THERAPY
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Utilizing adenovirus vectors for gene delivery in cancer
- (2014) Dayananda Kasala et al. Expert Opinion on Drug Delivery
- Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood
- (2014) Y Di et al. GENE THERAPY
- Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
- (2014) Carolien A. Koks et al. INTERNATIONAL JOURNAL OF CANCER
- Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease
- (2014) Jiqing Zhang et al. MOLECULAR THERAPY
- Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+T-cell response, prominent infiltration of CD8+lymphocytes and Th1 type polarization
- (2014) Tuuli Ranki et al. OncoImmunology
- Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
- (2014) Andrew Nguyen et al. Frontiers in Oncology
- Activated Ras Signaling Pathways and Reovirus Oncolysis: An Update on the Mechanism of Preferential Reovirus Replication in Cancer Cells
- (2014) Jun Gong et al. Frontiers in Oncology
- Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms
- (2013) S A Gujar et al. BRITISH JOURNAL OF CANCER
- Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers
- (2013) I-K Choi et al. CANCER GENE THERAPY
- Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
- (2013) C. J. Breitbach et al. CANCER RESEARCH
- Exposure-Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma
- (2013) Y. Feng et al. CLINICAL CANCER RESEARCH
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncolytic Vesicular Stomatitis Virus in an Immunocompetent Model of MUC1-Positive or MUC1-Null Pancreatic Ductal Adenocarcinoma
- (2013) E. Hastie et al. JOURNAL OF VIROLOGY
- Oncolytic virus therapy for cancer: the first wave of translational clinical trials
- (2013) Manish R. Patel et al. Translational Research
- Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy
- (2013) D. Ng Tang et al. Cancer Immunology Research
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β
- (2012) S Naik et al. CANCER GENE THERAPY
- Clinical Development of Oncolytic Viruses in China
- (2012) Min Liang CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets
- (2012) Gunnel Halldén et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Curative one-shot systemic virotherapy in murine myeloma
- (2012) S Naik et al. LEUKEMIA
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Vesicular stomatitis virus as a treatment for colorectal cancer
- (2011) J H Stewart et al. CANCER GENE THERAPY
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4
- (2011) J D Dias et al. GENE THERAPY
- Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD
- (2011) J J Rojas et al. GENE THERAPY
- Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18
- (2011) Gough G Au et al. Virology Journal
- A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer
- (2010) M. P. Lolkema et al. CLINICAL CANCER RESEARCH
- Oncolytic virotherapy of gynecologic malignancies
- (2010) Andreas D. Hartkopf et al. GYNECOLOGIC ONCOLOGY
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
- (2010) Anniina Koski et al. MOLECULAR THERAPY
- Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus
- (2010) Jan Brun et al. MOLECULAR THERAPY
- Gene medicine for cancer treatment: Commercially available medicine and accumulated clinical data in China
- (2010) Masatoshi Tagawa Drug Design Development and Therapy
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination
- (2009) M Takakura et al. CANCER GENE THERAPY
- Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells
- (2009) G. Wollmann et al. JOURNAL OF VIROLOGY
- Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
- (2009) Jing-Hua Huang et al. MOLECULAR THERAPY
- Oncolytic virotherapy for multiple myeloma
- (2008) Amaalia E Stief et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy
- (2008) Lan Wu et al. HUMAN GENE THERAPY
- Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
- (2008) Irene Kuhn et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started